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.doi.orgAbstract The present work involves synthesis of novel anti-fungal agents containing triazole scaf-
fold. The newly designed compounds were synthesized on the trails of ketoconazole using the
molecular hybridization approach. A series of 10 compounds having (2-((1H-1,2,4-triazol-1-
yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl esters (4a–j) were prepared by conven-
tional synthetic approach. The synthesized compounds were subjected for in vitro anti-fungal
screening against Aspergillus niger, Aspergillus fumigatus, Candida albicans and Penicillium notatum.
Out of 10 newly synthesized compounds, six compounds (4b–f and j) showed remarkable anti-fun-
gal activity (MIC range 6.5–25 lg/ml), whereas compound 4d (MIC 6.5 lg/ml) was more potent
than standard drug ketoconazole (MIC 12.5 lg/ml). These triazole hybrids can be considered as
potential anti-fungal agents.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Fungal infections pose a continuous and serious threat to hu-
man life. The severity of infection ranges from minor irrita-
tions such as athlete’s foot to life-threatening systemic
infections caused by Aspergillus fumigates (Uchida et al.,
2008). Hence the development of a potent, safe and selectiveepartment of Pharm. Chem.,
Pune 411041, India. Mobile:
16.
o.co.in (P.B. Miniyar).
Saud University.
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/10.1016/j.arabjc.2013.09.005antifungal agent is of prime importance for medicinal chemist
in the quest for effective chemotherapeutic treatment for fun-
gal diseases (Rezaei et al., 2009). At present antifungal treat-
ment with existing drugs proved to be less effective, due to
drug toxicity and drug resistance against a wide variety of fun-
gal species (Behbehani et al., 2011).
Triazole is an antifungal scaffold because of its high po-
tency and low toxicity (Xu et al., 2004). Hence many potent
antifungal compounds were developed in recent past by bio-
isosteric replacement of imidazole moiety with triazole (Acetti
et al., 2009). Triazole derivatives competitively inhibit lanos-
terol 14a-demethylase (CYP51), a key enzyme in sterol biosyn-
thesis of fungi. Based on the structure of the active site of
CYP51 and the extensive investigation of azole antifungals, tri-
azole inhibitors are able to ﬁt in the active site by H-bonding,
hydrophobic interactions and p–p stacking within the hemeing Saud University.
ybrids as new type of anti-fungal agents. Arabian Journal of
Scheme 1 Synthesis scheme for 4a–j compounds. R = Ali-
phatic/aromatic acid chloride; a = n-BuOH, Benzene, p-TsOH;
b = Br2, 25 C;c = Pyridine, 5 C, substituted acid chlorides;
d =NaH, Triazole, DMSO, 130 C.
2 P.B. Miniyar et al.environment of the enzyme (Upadhayaya et al., 2009; Kamal
et al., 2011).
The literature survey revealed that, many researchers devel-
oped potent anti-fungal agents by the molecular hybridization
approach using dioxolone with diazole/triazole moiety (Hiro-
michi and Yasushi, 2000; Dariusz and Andrzej, 2007; Fringu-
elli and Giacche, 2009; Xu and Cao, 2011). Well known drugs
viz. terconazole and itraconazole were developed as molecular
hybrids of triazole and dioxolone, whereas triazole moiety was
replaced by diazole in ketoconazole. The three crucial features
of clinically active anti-fungal agents are diazole/triazole ring,
aromatic ring and side chains (Fig. 1). Hence novel compounds
were developed on the trails of the above mentioned molecular
hybridization approach (Fig. 1).
2. Results and discussion
2.1. Chemistry
The targeted compounds were synthesized by a four-step
reaction process (Scheme 1). In the ﬁrst step, glycerol
and 2,4-dichloroacetophenone were used to synthesize
(2-(2,4-dichlorophenyl)-2-methyl-1,3-dioxolan-4-yl)methanol
(1) in the presence of p-toluene sulfonic acid. Compound (1)
was brominated by using bromine and glacial acetic acid to
obtain (2-(bromomethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-
4-yl)methanol (2). Intermediate (2) was converted into (2-
(bromomethyl)-2-(2,4-dichloroacetophenyl)-1,3-dioxolan-4-yl)
methyl ester (3) by reaction with corresponding aliphatic/
substituted and unsubstituted aromatic acid chlorides. Finally,
compounds (3) was stirred overnight with 50% sodium hy-
dride and 1,2,4-triazole to obtain (2-((1H-1,2,4-triazol-1-yl)-
methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl esters
(4a–j) (Table 1).
2.2. Biological activity
The anti-fungal activities of 4a–j were performed against
Aspergillus niger, Penicillium notatum, A. fumigatus and Can-
dida albicans (Odds and Vanden Bossche, 2000) and results
with respect to zone of inhibition and MIC are summarized
in Tables 2 and 3. Compound 4d which is benzenesulfonyl
methylester (MIC 6.5 lg/ml) was found more potent than ref-
erence standard ketoconazole (MIC 12.5 lg/ml), while com-
pound 4c, cinnamoyl methylester (MIC 12.5 lg/ml) was at
par with the reference standard. It was observed that in caseCl
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Figure 1 Comparison of ketoconazole and targeted anti-fungal
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agent. A = Iron coordinating group (diazole/triazole moiety);
drophobic group (side chain).
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Table 3 Anti-fungal activity of 4a–j compounds.
Molecule code MICa (lg/ml)
A. niger P. notatum A. fumigatus C. albicans
4a >50 >50 >50 >50
4b 25 >50 25 25
4c 12.5 12.5 12.5 12.5
4d 6.5 6.5 6.5 6.5
4e 25 25 25 25
4f 25 25 25 25
4g >50 >50 >50 >50
4h >50 >50 >50 >50
4i >50 >50 >50 >50
4j 25 12.5 12.5 25
Ketoconazole 12.5 12.5 12.5 12.5
a MIC: minimum inhibitory concentration.
Table 1 Physical data for 4a–j compounds.
Molecule code R Molecular formula
4a –COCH3 C15H15Cl2N3O4
4b –COCH2Cl C15H14Cl3N3O4
4c –COCH‚CH–C6H5 C22H19Cl2N3O4
4d –SO2C6H5 C19H17Cl2N3O5S
4e –COC6H5 C20H17Cl2N3O4
4f –COC6H4Cl(o) C20H16Cl3N3O4
4g –COC6H4Cl(m) C20H16Cl3N3O4
4h –COC6H4NH2(o) C20H18Cl2N4O4
4i –COC6H4NH2(p) C20H18Cl2N4O4
4j –COC6H4–CH3(o) C21H19Cl2N3O4
Triazole hybrids as new type of anti-fungal agents 3exhibited less anti-fungal activity as compared with standard
drug. However, compound 4j formed by esteriﬁcation with
o-methylbenzoyl chloride (MIC 12.5 lg/ml) was equally active
as that of standard drug against P. notatum and A. fumigates.
The present series could be developed as a novel class of
anti-fungal agents by further structural optimization.
3. Experimental
3.1. General
Melting points were determined in open capillaries using Vee-
go VMP-1 melting point apparatus and are uncorrected. The
IR spectra were recorded on JASCO FTIR 4100 series spec-
trometer. 1H NMR and 13C spectra were recorded on Varian
Mercury YH-300 at 300 MHz, in CDCl3 as a solvent and
TMS as internal standard. Peak values are shown in d ppm.
The mass spectra were recorded on Waters Q-ToF micro by
the electron spray ionization (ESI) method. Progress of the
reaction and purity of the compounds were conﬁrmed by
pre-coated TLC plates (Merck, 60F-254) and spots were visu-
alized using iodine vapor or UV light.
3.2. Chemistry
3.2.1. Synthesis of (2-(2,4-dichlorophenyl)-2-methyl-1,3-
dioxolan-4-yl)methanol (1) (Heeres and Hendickx, 1984)
Glycerol 1 g (0.02 mol) and 2,4-dichloroacetophenone 1.89 g
(0.01 mol) in 4 ml of toluene and 2 ml of n-butanol wereTable 2 Zone of Inhibition (mm) of test compound at 100 and 50
Compound code A. niger P. notatum
100 50 100 5
4a 5 3 4
4b 8 6 5
4c 10 8 9
4d 17 12 24 1
4e 9 7 6
4f 9 6 8
4g 7 4 6
4h 6 4 6
4i 5 4 6
4j 7 4 9
Ketoconazole 10 7 18 1
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drate (0.06 g) for 24 h with azeotropic removal of water. The
excess amount of toluene was removed on a rota evaporator
and the oily product 2-(2,4-dichlorophenyl)-1,3-dioxolane-4-
methanol (1) was obtained. Yield: 70%; B.P.: 130–132 C.
3.2.2. Synthesis of (2-(bromomethyl)-2-(2,4-dichlorophenyl)-
1,3-dioxolan-4-yl)methanol (2) (Furniss et al., 1989)
The oily product 2-(2,4-dichlorophenyl)-1,3-dioxolan-4-
yl)methanol (0.01 mol) was dissolved in glacial acetic acid
and cooled to 20 C, then into it bromine was added (1.92 g,
0. 012 mol) over a period of 2 h. The mixture was stirred for
0.5 h and then evaporated in vacuum to obtain product (2)
with 74% yield; B.P.: 182–184 C.
3.2.3. General procedure for the synthesis of (2-(bromomethyl)-
2-(2,4-dichloroacetophenyl)-1,3-dioxolan-4-yl) methyl ester
(3a–j) (Heeres and Hendickx, 1984)
The substituted acid chlorides (1.40 g, 0.01 mol) were added
dropwise at 5 C to a solution of compound 2 (3.1 g,
0.091 mol) in 6 ml of dry pyridine over a period of 1 h. The
mixture was stirred for 2.5 h and diluted with water. After
extraction with CHCl3, the organic layer was washed with
6 N HCl, dried (MgSO4) and evaporated in vacuum to leave
an oily residue which solidiﬁed on stirring with CH3OH and
obtained product 3a–j with yield 75–85%; B.P.: 194–196 C.lg/ml against. A. niger, P. notatum, A. fumigatus, C. albicans.
A. fumigatus C. albicans
0 100 50 100 50
3 6 4 7 4
3 7 5 6 4
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4 P.B. Miniyar et al.3.2.4. General procedure for the synthesis of aliphatic/
substituted aromatic esters of (2-((1H-1,2,4-triazol-1-
yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl
esters (4a–j)
Furniss et al., 1989 A suspension of 50% sodium hydride
(0.53 g, 0.011 mol) in dry DMSO 5 ml was added to triazole
(0.69 g, 0.01 mol) and compound 3 was mixed into it. It was
stirred at 130 C overnight. After the mixture was cooled, di-
luted with water and extracted with dichloromethane the or-
ganic extract was washed with water, dried and evaporated
in vacuum. An oily residue of the ﬁnal product (4) was ob-
tained with 60–85% yield; B.P.: 146–148 C.
Spectral data for 4a–j compounds are as follows where MS
(c) = calculated and (f) = found.
3.2.4.1. (2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichloro-
phenyl)-1,3-dioxolan-4-yl)methylacetate (4a).
Yield: 65%; B.P.: 180–182 C; FTIR (cm1): 814, 1290, 1600,
1732, 3092; 1H NMR (300 MHz, CDCl3, J Hz) d ppm: 2.0–2.3
(s, 3H, methyl), 4.5–4.6 (d, 2H, J= 9.6, 5.1, methylene), 4.0
(m, 1H, d, 2H, J= 8.2, 6.1; dioxolane), 4.8 (d, 2H,
J= 14.6; methylene), 7.0–7.9 (m, 3H, aromatic), 8.2–8.5 (s,
2H, triazole); 13C NMR (75 MHz, CDCl3) d ppm: 170.3
(C‚O), 151.2, 143.6 (C-triazole), 135.7, 134.6, 134.9, 130.4,
126.6 (C-aromatic), 105.1, 72.8, 67.6 (C-dioxolane), 65.7,
63.3 (C-methylene), 20.3 (C-methyl); MS (ESI): (c) 372.2033,
(f) 373.3690 [M+1]+.
3.2.4.2. (2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichloro-
phenyl)-1,3-dioxolan-4-yl)methyl-2-chloro acetate (4b). Yield:
62%; B.P.: 200–202 C; FTIR (cm1): 752, 1049, 1501, 1671,
3062; 1H NMR (300 MHz, CDCl3, J Hz) d ppm: 4.3 (s, 2H,
methylene), 4.5–4.6 (d, 2H, J= 9.8, 5.0, methylene), 4.3 (m,
1H, d, 2H, J= 8.0, 6.3; dioxolane), 4.5 (d, 2H, J= 13.6,
methyl), 7.2–7.9 (m, 3H, aromatic), 8.1–8.3 (s, 2H, triazole);
13C NMR (75 MHz, CDCl3) d ppm: 166.8 (C‚O), 151.3,
143.5 (C-triazole), 135.7, 134.6, 134.4, 130.5, 126.3 (C-aro-
matic), 105.0, 72.3, 67.7 (C-dioxolane), 64.4, 40.3 (C-methy-
lene); MS (ESI): (c) 406.6484, (f) 408.4762 [M+2]+.
3.2.4.3. (2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichloro-
phenyl)-1,3-dioxolan-4-yl)methyl- cinnamate (4c). Yield:
71%; B.P.: 250–253 C; FTIR (cm1): 759, 1200, 1693, 1789,
3021; 1H NMR (300 MHz, CDCl3, J Hz) d ppm: 6.4–6.5 (d,
2H, J= 10.2, vinyl), 4.5–4.9 (d, 2H, J= 9.8, 5.0, methylene),
3.9–4.0 (m, 1H, d, 2H, J= 7.8.0, 6.1; dioxolane), 4.5–4.9 (d,
2H, J= 14.2, methyl), 7.2–7.9 (m, 8H, aromatic), 8.1–8.2 (s,
2H, triazole); 13C NMR (75 MHz, CDCl3) d ppm: 166.4
(C‚O), 151.3, 145.9 (C-triazole), 143.4, 135.4, 134.6, 134.2,
130.2, 128.6, 126.7 (C-aromatic), 105.1, 72.2, 67.6 (C-dioxo-
lane), 65.7, 63.1 (C-methylene); MS (ESI): (c) 460.3100, (f)
483.2231 [M+Na]+.
3.2.4.4. (2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichloro-
phenyl)-1,3-dioxolan-4-yl)methyl- benzene sulfonate (4d).
Yield: 73%; B.P.: 217–219 C; FTIR (cm1): 723, 1259,
1592, 1683, 3122; 1H NMR (300 MHz, CDCl3, J Hz) d ppm:
4.3–4.7 (d, 2H, J= 10.0, 5.2, methyl), 3.7–3.9 (m, 1H, d,
2H, J= 8.0, 5.9; dioxolane), 4.5–4.9 (d, 2H, J= 14.0,
methyl), 7.0–7.8 (m, 8H, aromatic), 8.1–8.5 (s, 2H, triazole);
13C NMR (75 MHz, CDCl3) d ppm: 151.2 (C‚O), 143.5,Please cite this article in press as: Miniyar, P.B. et al., Triazole h
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105.3, 71.4, 67.5 (C-dioxolane), 63.0 (C-methylene); MS
(ESI): (c) 470.3264, (f) 471.3304 [M+1]+.
3.2.4.5. (2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichloro-
phenyl)-1,3-dioxolan-4-yl)methyl-benzoate (4e). Yield: 75%;
B.P.: 160–162 C; FTIR (cm1): 723, 1259, 1590, 1690, 3122;
1H NMR (300 MHz, CDCl3, J Hz) d ppm: 4.2–4.6 (d, 2H,
J= 10.1, 5.2, methylene), 3.7–3.9 (m, 1H, d, 2H, J= 8.4,
5.9; dioxolane), 4.7–4.9 (d, 2H, J= 14.4, methylene), 7.1–7.4
(m, 8H, aromatic), 8.1–8.3 (s, 2H, triazole); 13C NMR
(75 MHz, CDCl3) d ppm: 166.1 (C‚O), 151.3, 143.5 (C-tria-
zole), 135.5, 134.8, 133.2, 130.2, 129.9, 128.6, 126.7 (C-aro-
matic), 105.1, 72.1, 67.5 (C-dioxolane), 65.2, 63.1(C-
methylene); MS (ESI): (c) 434.2727, (f) 435.1697 [M+1]+.
3.2.4.6. (2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichloro-
phenyl)-1,3-dioxolan-4-yl)methyl-2-chloro- benzoate (4f).
Yield: 78%; B.P.: 190–192 C; FTIR (cm1): 740, 1041,
1506, 1702, 2312; 1H NMR (300 MHz, CDCl3, J Hz) d ppm:
4.1–4.4 (d, 2H, J= 9.6, 4.8, methylene), 3.7–3.9 (m, 1H, d,
2H, J= 8.2, 5.9; dioxolane), 4.7–4.9 (d, 2H, J= 14.0, methy-
lene), 7.0–7.5 (m, 7H, aromatic), 8.0–8.2 (s, 2H, triazole); 13C
NMR (75 MHz, CDCl3) d ppm: 166.1 (C‚O), 151.3, 143.4
(C-triazole), 134.4, 131.7, 130.1, 128.6, 126.9 (C-aromatic),
105.1, 72.4, 67.4 (C-dioxolane), 63.1, 60.3 (C-methylene); MS
(ESI): (c) 468.7177, (f) 470.0233 [M+2]+.
3.2.4.7. (2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichloro-
phenyl)-1,3-dioxolan-4-yl)methyl-3-chloro- benzoate (4g).
Yield: 60%; B.P.: 287–289 C; FTIR (cm1): 759, 1020,
1583, 1693, 3087; 1H NMR (300 MHz, CDCl3, J Hz) d ppm:
4.0–4.3 (d, 2H, J= 9.4, 4.6, methylene), 3.5–3.7 (m, 1H, d,
2H, J= 8.0, 5.7; dioxolane), 4.5–4.7 (d, 2H, J= 14.2, methy-
lene), 7.1–7.6 (m, 7H, aromatic), 8.0–8.2 (s, 2H, triazole); 13C
NMR (75 MHz, CDCl3) d ppm: 166.0 (C‚O), 151.3, 134.4
(C-triazole), 133.2, 131.5, 130.3, 128.8, 126.6 (C-aromatic),
105.0, 72.4 (C-dioxolane), 65.1, 63.2 (C-methylene); MS
(ESI): (c) 468.7177, (f) 469.0277 [M+1]+.
3.2.4.8. (2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichloro-
phenyl)-1,3-dioxolan-4-yl)methyl-2-amino- benzoate (4h).
Yield: 80%; B.P.: 228–232 C; FTIR (cm1): 1259, 3122,
1730, 1685, 758, 3413; 1H NMR (300 MHz, CDCl3, J Hz) d
ppm: 4.0 (s, 2H, NH), 4.1–4.2 (d, 2H, J= 9.2, 4.4, methylene),
3.6–3.8 (m, 1H, d, 2H, J= 8.2, 5.8; dioxolane), 4.4–4.6 (d, 2H,
J= 14.0, methylene), 7.1–7.7 (m, 7H, aromatic), 8.1–8.3 (s,
2H, triazole); 13C NMR (75 MHz, CDCl3) d ppm: 166.1
(C‚O), 151.3, 150.3 (C-triazole), 135.6, 134.6, 133.7, 130.4,
126.8 (C-aromatic), 118.6, 116.4, 105.0 (C-dioxolane), 72.2,
65.2, 63.0 (C-methylene); MS (ESI): (c) 449.2873, (f)
451.3545 [M+2]+.
3.2.4.9. (2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichloro-
phenyl)-1,3-dioxolan-4-yl)methyl-4-amino- benzoate (4i).
Yield: 85%; B.P.: 270–272 C; FTIR (cm1): 757, 1256,
1594, 1673, 2929; 1H NMR (300 MHz, CDCl3, J Hz) d ppm:
4.0 (s, 2H, NH), 4.2–4.4 (d, 2H, J= 9.3, 4.5, methylene),
3.7–3.9 (m, 1H, d, 2H, J= 8.0, 5.6; dioxolane), 4.4–4.6 (d,
2H, J= 14.2, methylene), 7.1–7.4 (m, 7H, aromatic), 8.0–8.4
(s, 2H, triazole); 13C NMR (75 MHz, CDCl3) d ppm: 166.3ybrids as new type of anti-fungal agents. Arabian Journal of
Triazole hybrids as new type of anti-fungal agents 5(C‚O), 152.5, 151.1 (C-triazole), 143.6, 135.4, 134.1, 130.6,
126.9 (C-aromatic), 120.2, 116.3, 105.2, 72.0, 67.6, 65.1, 63.0
(C-methylene); MS (ESI): (c) 449.2873, (f) 450.2034 [M+1]+.
3.2.4.10. (2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichloro-
phenyl)-1,3-dioxolan-4-yl)methyl-2-benzoate (4j). Yield:
76%; B.P.: 290–292 C; FTIR (cm1): 869, 1259, 1592, 1633,
3122; 1H NMR (300 MHz, CDCl3, J Hz) d ppm: 2.2 (s, 3H,
CH3), 4.0–4.3 (d, 2H, J= 9.1, 4.4, methylene), 3.7–3.9 (m,
1H, d, 2H, J= 8.1, 5.5; dioxolane), 4.4–4.6 (d, 2H,
J= 14.0, methylene), 7.0–7.5 (m, 7H, aromatic), 8.1–8.2 (s,
2H, triazole); 13C NMR (75 MHz, CDCl3) d ppm: 166.0
(C‚O), 151.2, 143.6 (C-triazole), 139.4, 135.0, 134.6, 133.1,
130.5, 129.6, 126.9 (C-aromatic), 120.6, 105.1, 72.1, 67.5,
65.4, 63.1 (C-methylene); MS (ESI): (c) 448.2993, (f)
449.0711 [M+1]+.
3.2.5. Biological activity
A. niger (NCIM 592), P. notatum (NCIM 745), A. fumigatus
(NCIM 535) and C. albicans (NCIM 3471) were obtained from
National Collection of Industrial Microorganism (NCIM),
National Chemical Laboratory (NCL), Pune, India. The dif-
ferent concentrations of all test compounds were prepared in
DMSO at 5–50 lg/ml. Ketoconazole was used as standard.
Micro dilutions for control experiments were performed as de-
scribed by Galgiani (1993) and National Committee for Clin-
ical Laboratory Standards (1997).Acknowledgement
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